Janice Massey, MD, Professor of Neurology and Senior Vice Chair of the Department of Neurology has been awarded the Lifetime Achievement Award by The American Association of Neuromuscular & Electrodiagnostic Medicine, (AANEM) in recognition of her decades of service to patient care and the field of neurology.

Provost Kornbluth and Dean Klotman discuss the biology of omicron and how Duke is adapting its policies.

Duke researchers have identified a genomic signature which makes it possible to develop a test to identify which men should undergo treatment early in their diagnosis, vs. those who could safely postpone therapy, if they need it at all.

Your taste buds may or may not be able to tell real sugar from a sugar substitute like Splenda, but there are cells in your intestines that can and do distinguish between the two sweet solutions. And they can communicate the difference to your brain in milliseconds.

Dr. L. Ebony Boulware, is the first-author on a perspective in New England Journal of Medicine (NEJM) published Saturday, entitled, Combating Structural Inequities — Diversity, Equity, and Inclusion in Clinical and Translational Research.

ALICE – Academic Leadership, Innovation, and Collaborative Engagement –  is year-long a leadership development opportunity for mid-career women faculty in the School of Medicine

The awards program supports promising, early career physician-scientists at Duke as they develop independent research programs. Each recipient will receive $75,000 annually for three years to support their research programs.

The School of Medicine Office for Faculty is pleased to announce the 2022 Duke Clinical Leadership Program (DCLP) participants.

Get vaccinated against COVID-19 or you dramatically increase your risk of ending up on a ventilator and further taxing local hospitals as local cases of the virus surge. That’s the message from chief medical officers from three Triangle health systems during a media briefing Thursday. Watch the briefing here.

Geoff Ginsburg, MD, PhD, professor of medicine, pathology, and biostatistics and bioinformatics, and the founding director of MEDx (Medicine + Engineering at Duke), will step down as director in January 2022. In an interview, he reflects on the creation of MEDx and its accomplishments, people, growth, and more.